Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun 15;61(6):2300616.
doi: 10.1183/13993003.00616-2023. Print 2023 Jun.

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

Alvar Agustí  1 , Antonio Anzueto  2 , Bartolome R Celli  3 , Kevin Mortimer  4   5   6 , Sundeep Salvi  7 , Claus F Vogelmeier  8 ; GOLD Scientific Committee
Affiliations
Comment

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

Alvar Agustí et al. Eur Respir J. .

Abstract

The GOLD Scientific Committee respond to five letters to the Editor in relation to the GOLD 2023 Executive Summary https://bit.ly/41wJzhk

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A. Agustí is Chair of the Board of Directors of GOLD (no payment received), and reports grants or contracts from AZ, GSK, Chiesi and Menarini, consultancy fees from AZ, GSK, Chiesi, Menarini, Zambon, MSD and Sanofi, and payment or honoraria for lectures, presentations, manuscript writing or educational events from AZ, GSK, Chiesi, Menarini and Zambon, outside the submitted work. A. Anzueto reports consultancy fees from GlaxoSmithKline, AstraZeneca and Boehringer Ingelheim, and payment or honoraria for lectures, presentations, manuscript writing or educational events from Viatrix Pharma, outside the submitted work. B.R. Celli reports support for the present work from Chiesi Farmaceutici; grants or contracts from GlaxoSmithKline, AstraZeneca, Menarini, Sanofi Aventis and Axios, consultancy fees from GlaxoSmithKline, AstraZeneca and Sanofi Aventis, payment or honoraria for lectures, presentations, manuscript writing or educational events from GlaxoSmithKline, AstraZeneca, Menarini, Chiesi and Regeneron, support for attending meetings and/or travel from GlaxoSmithKline and Sanofi Aventis, and participation on a data safety monitoring board or advisory board for AZ Therapeutics, Sanofi Aventis and Vertex, outside the submitted work. K. Mortimer has contributed to advisory boards for AstraZeneca and GlaxoSmithKline, outside the submitted work. S. Salvi has no potential conflicts of interest to disclose. C.F. Vogelmeier reports grants or contracts from German Ministry of Education and Science (BMBF), AstraZeneca, Boehringer Ingelheim, Chiesi, CSL Behring, GlaxoSmithKline, Grifols and Novartis, consultancy fees from Aerogen, AstraZeneca, Boehringer Ingelheim, CSL Behring, Chiesi, GlaxoSmithKline, Insmed, Menarini, Novartis and Nuvaira, and payment or honoraria for lectures, presentations, manuscript writing or educational events from Aerogen, AstraZeneca, Boehringer Ingelheim, CSL Behring, Chiesi, GlaxoSmithKline, Insmed, Menarini, Novartis, Roche and Sanofi, outside the submitted work.

Comment on

  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
    Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, López Varela MV, Wedzicha JA, Vogelmeier CF. Agustí A, et al. Eur Respir J. 2023 Apr 1;61(4):2300239. doi: 10.1183/13993003.00239-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 36858443 Free PMC article.

References

    1. Agustí A, Celli BR, Criner GJ, et al. . Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J 2023; 61: 2300239. doi:10.1183/13993003.00239-2023 - DOI - PMC - PubMed
    1. Halpin DMG, Celli BR, Criner GJ, et al. . The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis 2019; 23: 1131–1141. doi:10.5588/ijtld.19.0397 - DOI - PubMed
    1. Meghji J, Mortimer K, Agusti A, et al. . Improving lung health in low-income and middle-income countries: from challenges to solutions. Lancet 2021; 397: 928–940. - PubMed
    1. Mortimer K, Montes de Oca M, Salvi S, et al. . Household air pollution and COPD: cause and effect or confounding by other aspects of poverty? Int J Tuberc Lung Dis 2022; 26: 206–216. doi:10.5588/ijtld.21.0570 - DOI - PMC - PubMed
    1. Pan African Thoracic Society . Spirometry Training. 2023. https://panafricanthoracic.org/training/spirometry-training

MeSH terms